Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

162558

Sigma-Aldrich

4-Fluoro-2-nitroaniline

97%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
FC6H3(NO2)NH2
CAS Number:
364-78-3
Molecular Weight:
156.11
Beilstein:
2210197
EC Number:
206-666-0
MDL number:
MFCD00007830
UNSPSC Code:
12352100
PubChem Substance ID:
24849991
NACRES:
NA.22

Assay

97%

mp

90-94 °C (lit.)

SMILES string

Nc1ccc(F)cc1[N+]([O-])=O

InChI

1S/C6H5FN2O2/c7-4-1-2-5(8)6(3-4)9(10)11/h1-3H,8H2

InChI key

PUGDHSSOXPHLPT-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

4-Fluoro-2-nitroaniline forms complexes with cobalt(II), nickel(II) and copper(II).

Application

4-Fluoro-2-nitroaniline was used as starting reagent in the synthesis of 4-fluoro-N-ethyl-2-nitroaniline and N-(4-fluoro-2-nitrophenyl)-β-alanine.

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

WGK

WGK 3

Flash Point(F)

192.2 °F

Flash Point(C)

89 °C

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Complexes of copper (II), nickel (II) and cobalt (II) with 2-fluoro, 5-nitroaniline and 4-fluoro, 2-nitroaniline.
DeVoto G, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 38(7), 725-728 (1982)
S Singh et al.
The Journal of pharmacology and experimental therapeutics, 296(2), 600-611 (2001-02-13)
The diseases of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are characterized by mucus-congested airways. Agents that stimulate the secretion of Cl- are anticipated to facilitate mucociliary clearance and thus be of benefit in the treatment of CF
Thomas Hussenether et al.
Bioorganic & medicinal chemistry, 12(10), 2625-2637 (2004-04-28)
Novel 4-arylpiperazin-1-yl-substituted 2,3-dihydro-1H-1,4- and 1H-1,5-benzodiazepines and their aza-analogues were synthesized as debenzoclozapine derivatives for evaluation as potential D4-ligands. While Ki values of some of the title compounds came within the range of clozapine, they showed an impressively greater selectivity over

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service